MENU
GMAB
AS OF
Dec 24 closing price
Price
$33.72
Change
+$0.07 (+0.21%)
Capitalization
20.65B
42 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genmab A/S ADS (GMAB) Ownership - Who owns Genmab A/S ADS?

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.65B
P/E Ratio
14.76
Total Cash
3.41B
Projected Growth
0.65
Total Debt
142M
Revenue
3.47B
Risk (Beta)
0.82
Dividend Yield
N/A
Total Cash/Share
5.54
Total Debt/Equity
N/A
Revenue/Share
5.50 USD as % of share price

Fundamentals

GMAB
Capitalization
20.6B
P/E Ratio
14.76
Risk (Beta)
0.82
Dividend Yield
N/A
Total Cash
3.41B
Total Cash/Share
5.54
Total Debt
142M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.65
Revenue/Share (as % of the share price)
5.50%
Revenue
3.47B
ROE
N/A
Book Value
5.75B
P/B Ratio
3.61
Cash Flow
N/A
Earnings
2.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10M
Current Ratio
6.03
Current Revenue Per Employee
381201.03
Dividends Per Share - Security
N/A
EBITDA
1.71B
Float
N/A
Float - Current
N/A
Gross Income Margin
94.32
Revenue To Assets
22.30
Shares Held By Institutions
27.3B
Shares Outstanding - Current
616M
Total Liabilities
1.27B
Total Volume MTD
N/A
Value
N/A
Gain YTD
61.572
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GMAB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GMAB showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GMAB
A.I. Advisor
published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com